Jump to section
Uses Dosing Protocol Reconst Inject Supplies Source Works Effects

AOD-9604

AOD-9604 is studied for how it signals fat cells to break down stored fat while also helping limit the formation of new fat. Unlike growth hormone, it focuses specifically on fat metabolism without influencing blood sugar or growth-related pathways.

Research suggests it may help the body favor fat burning while preserving lean tissue.

Metabolic Fat Loss Body Composition

Common Research Uses

  • Supporting fat breakdown (lipolysis)
  • Reducing fat storage processes
  • Body composition research
  • Metabolic efficiency studies

Typical Research Dosing

Daily Range: 300–500 mcg
Frequency: Once daily
Common Cycle Length: 4–12 weeks
🧮 Calculate dose → 💧 Reconstitution steps 📥 View QuickStart card

Subcutaneous Protocol (5 mg + 2 mL BAC = 2.5 mg/mL)

Phase Daily Dose (mg) Units per Injection
Weeks 1-4 300 mcg once daily 12 units
Weeks 5-12 500 mcg once daily 20 units
Alternative BID 2.5 mg twice daily 100 units (1.0 mL) × 2

Based on reconstitution of 5 mg with 2 mL bacteriostatic water (2.5 mg/mL).

Reconstitution Steps

Your Mix: 5 mg peptide + 2 mL bacteriostatic water = 2.5 mg/mL
  1. Prep clean: Wash hands, use a clean surface, and gather supplies.
  2. Sanitize: Alcohol swab vial stoppers and allow to air-dry.
  3. Add diluent slowly: Inject bacteriostatic water down the vial wall to reduce foaming.
  4. Mix gently: Gently swirl or roll until fully dissolved. Do not shake.
  5. Label: Write compound name, date, and concentration (mg/mL).
  6. Store appropriately: Store according to supplier guidance and maintain sterile technique.

Educational reference only

Injection Technique

General subcutaneous guidance from clinical best-practice resources.

  • Allow the peptide to reach room temperature before injection.
  • Clean the vial stopper and injection site with alcohol and allow to fully dry.
  • Pinch a small skinfold and insert the needle at a 45–90° angle into subcutaneous tissue.
  • Do not aspirate for subcutaneous injections; inject slowly and steadily.
  • Rotate injection sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.
  • Inject slowly to help minimize any stinging sensation.

This information is provided for educational reference only and reflects general clinical best practices.

Supplies Needed (Auto Calculator)

Inventory planning tool. Choose presets or enter your own values.

Preset weeks
Preset vials (5 mg each)
Syringes (U-100)
—
— / week
Bacteriostatic water
— mL
— bottle(s)
Alcohol swabs
—
— box(es)
Shop at MADDOG Peps →

Notes: Syringes = (weeks × 7 × injections/day). Swabs = (syringes × swabs/injection). BAC = (vials × mL per vial). Bottles/boxes are rounded up.

How It Works

AOD-9604 is a modified C-terminal fragment of human growth hormone that retains the fat-reducing (lipolytic) portion of the hormone without the growth-promoting effects.

It works by targeting fat tissue directly. In adipose tissue, AOD-9604 helps stimulate the breakdown of stored fat while also limiting the process that allows fat cells to store new fat (re-esterification).

At a cellular level, longer-term use has been shown to increase activity of β3-adrenergic receptors in fat tissue. These receptors play an important role in regulating fat burning, and their activity is often reduced in obesity. Unlike full-length human growth hormone, AOD-9604 does not significantly raise IGF-1 levels or negatively impact blood sugar control. In human studies, its safety profile has been reported as comparable to placebo.

Commonly Reported Side Effects

  • Mild Headache
  • Fatigue
  • Nausea
  • Injection site reactions

These effects are based on commonly reported research observations and may vary by individual.

↑